| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |